Abstract: A system for collection and analysis of regularly retrieved patient information for automated remote patient care is presented. A medical device having a sensor for monitoring at least one physiological measure of an individual patient regularly records and stores measures sets including individual measures relating to patient information. A database collects one or more patient care records by organizing one or more patient care records with a plurality of the collected measures sets and storing the collected measures set into a patient care record for the individual patient. A server periodically receives a set of the collected measures retrieved on a substantially regular basis from the medical device, and analyzes one or more of the collected measures sets in the patient care record for the individual patient relative to one or more other collected measures sets stored in the database server to determine a patient status indicator.
Abstract: A full-body charger for charging one or more battery-powered devices wherein such devices are configured for implanting beneath a patient's skin for the purpose of tissue, e.g., nerve or muscle, stimulation and/or parameter monitoring and/or data communication. Devices in accordance with the invention include a support structure, typically chair-shaped or bed-shaped, capable of supporting a patient's body while providing a magnetic field to one or more of the implanted devices using one or more coils mounted within for providing power to the implanted devices. Consequently, in a preferred embodiment, a single, generally sequential, charging cycle can charge all of the implanted devices and thus minimize the charge time requirements for a patient and accordingly improve the patient's life style.
Type:
Grant
Filed:
October 16, 2002
Date of Patent:
September 12, 2006
Assignee:
Alfred E. Mann Foundation for Scientific Research
Inventors:
Joseph H. Schulman, Carla Mann, Lee J. Mandell
Abstract: Apparatus and method for monitoring capacitive elements of an implantable medical device system for device failure and responding thereto. A therapy measurement block monitors a charge value across one or more capacitive elements. If the charge value falls outside a prescribed range, indicating possible failure in the capacitive element, the system removes from service the capacitive element and its associated regulator, notifies the implantable neuro stimulator of the failure and/or takes appropriate corrective measures.
Type:
Grant
Filed:
April 26, 2002
Date of Patent:
August 8, 2006
Assignee:
Medtronic, Inc.
Inventors:
Todd D. Heathershaw, Nathan A. Torgerson, Mark Stein
Abstract: A system and method for providing tiered patient feedback for use in automated patient care is described. Physiological measures are analyzed. Each physiological measure is representative of at least one of measured and derived patient information recorded on a substantially continuous basis and was retrieved from one such patient care record to determine a patient status. Tiered feedback is provided to an individual patient responsive to the patient status.
Abstract: A vest for providing electrical stimulation is disclosed. The vest includes front and rear sections and a controller. Left front and right front electrodes are provided on interior surfaces of the front section, and left rear and right rear electrodes are provided on interior surfaces of the rear section. The controller is provided on an exterior surface of the front section and provides selectively adjustable electrical pulse signals to the electrodes via wires routed over the exterior surface of the front and rear sections to the electrodes through respective openings provided in the front and rear sections. The electrodes and the front and rear sections include means for positional adjustment of the electrodes on the interior surfaces of the front and rear sections. The vest can be used for electrical stimulation of muscles or nerves of the abdomen and back for users having varying body types and sizes.
Abstract: A system and method for discriminating cardiac rhythms occurring in an antegrade direction from cardiac rhythms occurring in a retrograde direction. Atrial and ventricular contractions are sensed, from which atrial and ventricular cycle lengths are determined. Ventricular contractions are also analyzed to determine the occurrence of a tachycardia episode that has a one-to-one association of atrial contractions to ventricular contractions. During a tachycardia episode having a one-to-one association of atrial contractions to ventricular contractions, the atrial cycle lengths are paired with the ventricular cycle lengths, where for each of the atrial cycle lengths the atrial cycle length is paired with at least one ventricular cycle length started before the first atrial contraction of each of the atrial cycle lengths and paired with at least one ventricular cycle length started after the first atrial contraction of each of the atrial cycle lengths.
Abstract: A biatrial and/or biventricular pacing system is used in a diagnostic context. By placing a pacing/sensing lead in three or four chambers of the heart, various conduction sequences can be determined and the originating chamber of various arrhythmias can be identified. This information is stored temporarily in the pacemaker until it is extracted for analysis.
Abstract: A method for recording into a memory of a cardiac event recorder, in which the memory of the cardiac event recorder includes a manual trigger memory and an auto-trigger memory, with the auto-trigger memory being partitioned into a plurality of auto-trigger recording partitions, the method includes the steps of continuously recording signals, in the event of a manual trigger, acquired from the manual trigger or the auto-trigger in the manual trigger memory, and copying the signals acquired from the auto-trigger from the manual trigger memory to a partition of the auto-trigger memory.
Abstract: A process for stimulating tissue such as cardiac tissue, nerve tissue, and brain tissue. In one step of the process, there is delivered an electrical stimulating signal to the tissue that contains from about 10 to about 1,000 individual pulses. Each individual pulse has a duration of from about one microsecond to about 100 microseconds and is discontinuous, with a spacing between adjacent pulses of at least from about 1 microsecond to about 100 microseconds. The individual pulses have a voltage of from about 10 millivolts to about 100 volts.
Abstract: A cardiac rhythm management system predicts when an arrhythmia will occur and in one embodiment invokes a therapy to prevent or reduce the consequences of the arrhythmia. A cardiac arrhythmia trigger/marker is detected from a patient, and based on the trigger/marker, the system estimates a probability of a cardiac arrhythmia occurring during a predetermined future time interval. The system provides a list of triggers/markers, for which detection values are recurrently obtained at various predetermined time intervals. Based on detection values and conditional probabilities associated with the triggers/markers, a probability estimate of a future arrhythmia is computed. An arrhythmia prevention therapy is selected and activated based on the probability estimate of the future arrhythmia.
Abstract: Techniques are described for overdrive pacing the heart using a pacemaker wherein the overdrive pacing rate only increases when at least two intrinsic beats are detected within a determined search period. In one specific technique, an increase in the pacing rate occurs only if two P-waves are detected within X cardiac cycles. In another specific technique, the overdrive pacing rate is increased only if at least two P-waves are detected within a block of N cardiac cycles. In both techniques, the overdrive pacing rate is decreased if no increase has occurred in the last Z cardiac cycles. By increasing the overdrive pacing rate only in response to detection of at least two P-waves within a determined number of cardiac cycles, an excessively high overdrive pacing rate is avoided. Other techniques are described for adaptively adjusting overdrive pacing parameters so as to achieve a determined target degree of pacing of, for example, 95% paced beats.
Type:
Grant
Filed:
December 18, 2002
Date of Patent:
May 9, 2006
Assignee:
Pacesetter, Inc.
Inventors:
Joseph J. Florio, Gene A. Bornzin, John W. Poore, Douglas T. Kurschinski
Abstract: A lead employing a connection between a conductor and an electric element is provided. The connection includes a conductive pad electrically connected to at least one conductor and the electric element electrically connected to the conductive pad. The conductive pad can further include an elongated element to connect the pad to the electric element. The method for connecting a conductor to an electric element is also provided. The method includes forming a groove in the insulator of a lead body to expose the conductor. Placing a conductive pad within the groove and electrically connecting a conductive pad to the conductor. An electric element is then placed over the conductive pad and the electric element is electrically connected to the conductive pad.
Abstract: Methods of using electrical stimulation by itself or in conjunction with growth factors to treat and prevent visual loss due to choroidal, retinal pigment epithelial and/or neuroretinal cell degeneration and dysfunction are presented.
Abstract: Various embodiments can permit electrode configurations that are used in implantable devices to be automatically changed. In some embodiments, configurations that are used to ascertain capture (ventricular and/or atrial) can be automatically changed by a stimulation device and then automatically configured for use. Various parameters associated with the electrical configurations can be automatically calibrated so that a stimulation device's automatic capture feature can continue to function notwithstanding the fact that an electrode configuration change has taken place.
Abstract: T-wave amplitude and QT interval are derived from patient cardiac signals. Then blood glucose levels are determined based on a combination of the T-wave amplitude and the QT interval. By using a combination of both T-wave-based and QT interval-based signals, blood glucose levels can be reliably detected throughout a wide range of blood glucose levels. Once the blood glucose level has been detected, the implanted device compares the blood glucose level against upper and lower acceptable bounds and appropriate warning signals are generated if the level falls outside the bounds. In one example, wherein an implantable insulin pump is additionally provided, the pump is controlled based on the detected blood glucose level to maintain glucose levels within an acceptable range. A calibration technique is also provided for determining patient-specific parameters for use in the detection of blood glucose levels.
Abstract: A method and apparatus are provided for protecting cardiac tissue from insult. The method comprises identifying the occurrence of an insult, such as a heart attack, and delivering electrical stimulation to one or more predetermined nerves in a patient's body in response to identifying the occurrence of the insult. The stimulation may be provided at the spinal canal or on the chest wall of the patient through cutaneous electrodes.
Type:
Grant
Filed:
October 26, 2001
Date of Patent:
March 7, 2006
Assignee:
Medtronic, Inc.
Inventors:
Michael R. S. Hill, Gary W. King, Thomas J. Mullen, Xiaohong Zhou
Abstract: An arrangement and method are presented that enable a prediction of an abnormality and implement a suitable action opposing the abnormality. An information flow underlying a dynamic system is interpreted and a prediction quantity that comprises the abnormality as characterizing quantity of the dynamic system is determined from it. A neural network is trained with measured data of the system. After the training, the abnormality can be indicated on the basis of the prediction quantity before it occurs and the occurrence can be opposed with suitable measures.
Abstract: A system and method for processing normalized voice feedback for use in automated patient care is described. One or more physiological measures relating to individual patient information and one or more quality of life measures relating to normalized spoken patient self-assessment indicators are retrieved from a patient care record. Each quality of life measure is recorded substantially contemporaneous to the physiological measures. The physiological measures and the contemporaneously recorded quality of life measures retrieved from one such patient care record are analyzed to determine a patient status.
Abstract: A high-density multichannel microwire electrode array is disclosed. The array can comprise a variable number of electrodes. A method of assembling the array is further disclosed. Additionally, a plurality of devices employing the array are disclosed, including an intelligent brain pacemaker and a closed loop brain machine interface.
Type:
Grant
Filed:
March 14, 2002
Date of Patent:
January 31, 2006
Assignee:
Duke University
Inventors:
Miguel A. L. Nicolelis, Gary C. Lehew, David J. Krupa
Abstract: Techniques are described for overdrive pacing the heart using a pacemaker. Other techniques are described for adaptively adjusting overdrive pacing parameters so as to achieve a determined target degree of pacing of, for example, 95% paced beats. By adaptively adjusting overdrive parameters to maintain a target degree of pacing, the average overdrive pacing rate is minimized while still maintaining a high number of paced beats, thereby reducing the risk of a tachyarrhythmia occurring within the patient. Still other techniques are described for increasing an overdrive pacing rate by an amount related to a current overdrive pacing rate.
Type:
Grant
Filed:
April 4, 2002
Date of Patent:
January 24, 2006
Assignee:
Pacesetter, Inc.
Inventors:
Joseph J. Florio, Gene A. Bornzin, John W. Poore, Douglas T. Kurschinski